Park Il Soon, Yoon Jong Seo, So Cheol Hwan, Lee Hae Sang, Hwang Jin Soon
Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
Ann Pediatr Endocrinol Metab. 2017 Jun;22(2):115-118. doi: 10.6065/apem.2017.22.2.115. Epub 2017 Jun 28.
Congenital hypothyroidism (CH) is the most common cause of preventable mental retardation. Recently, the detection of CH cases with eutopic thyroid gland has increased due to neonatal screening programs. In this study, we aimed to identify and evaluate predictive factors that could distinguish between permanent and transient CH in patients with eutopic thyroid gland.
We retrospectively reviewed 100 children diagnosed with CH and with eutopic thyroid gland. All subjects were treated with levothyroxine and underwent re-evaluation after 3 years of age.
Of the 100 CH patients, 35 (35.0%) were diagnosed with permanent CH (PCH) and 65 (65.0%) were diagnosed with transient CH (TCH). The initial thyroid stimulating hormone levels were significantly lower in the TCH subjects than in PCH subjects. In addition, the mean doses of levothyroxine (µg/kg/day) at the 1st, 2nd, and 3rd year of treatment were significantly lower in subjects with TCH than in PCH subjects with eutopic thyroid gland. Based on the receiver operating characteristic (ROC) curve, the optimal cutoff dose of levothyroxine at 3 years of 2.76 µg/kg/day could predict TCH, and was associated with 87.3% sensitivity and 67.6% specificity, with an area under the ROC curve of 0.769.
The levothyroxine dose requirement during treatment period has a predictive role in differentiating TCH from PCH in CH patients with eutopic thyroid gland.
先天性甲状腺功能减退症(CH)是可预防的智力发育迟缓的最常见原因。近年来,由于新生儿筛查项目,甲状腺位置正常的CH病例的检出率有所增加。在本研究中,我们旨在识别和评估可区分甲状腺位置正常的患者永久性和暂时性CH的预测因素。
我们回顾性分析了100例诊断为CH且甲状腺位置正常的儿童。所有受试者均接受左甲状腺素治疗,并在3岁后进行重新评估。
100例CH患者中,35例(35.0%)被诊断为永久性CH(PCH),65例(65.0%)被诊断为暂时性CH(TCH)。TCH受试者的初始促甲状腺激素水平显著低于PCH受试者。此外,TCH受试者在治疗第1年、第2年和第3年的左甲状腺素平均剂量(μg/kg/天)显著低于甲状腺位置正常的PCH受试者。根据受试者工作特征(ROC)曲线,3岁时左甲状腺素的最佳截断剂量为2.76 μg/kg/天可预测TCH,其灵敏度为87.3%,特异度为67.6%,ROC曲线下面积为0.769。
治疗期间左甲状腺素的剂量需求在区分甲状腺位置正常的CH患者的TCH和PCH方面具有预测作用。